The emergence of AI and biosensors offers a chance to address inefficiencies in drug development.

A marriage of formal methods and LLMs seeks to harness the strengths of both.

When leaders think about data, structured data—such as payment amounts, invoice processing dates and customer names—likely crosses their minds first. Because structured data is objective, it’s ...